Abbott's Compounding Pharmacy Recalls Sterile Compounded Products Due to Sterility Concerns
Abbott's Compounding Pharmacy is recalling all unexpired lots of sterile compounded products after an FDA inspection identified concerns regarding the lack of sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. The hazard involves a lack of sterility assurance in sterile compounded products, which poses a significant risk of serious injury or infection, fitting the 'Severe' criteria for significant injury reports or high-risk contamination.
Plain-English summary
Abbott's Compounding Pharmacy, Inc. is recalling all unexpired lots of sterile compounded products. The recall was initiated after an FDA inspection found concerns regarding the lack of sterility assurance for these products.
The affected products include papaverine phentolamine prostaglandin (35/1.2 mg/20 mcg/mL) in 10 mL unit sizes. These are compounded prescriptions that require refrigeration. The recall covers all lots of the sterile compounded products.
Consumers who have these products should stop using them and contact their healthcare provider or pharmacist for further instructions. The recall is limited to California (CA).
The recalled product
- Product
- papaverine phentolamine prostaglandin; 35/1.2 mg/20 mcg/mL; 10 mL unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705
- Manufacturer
- Abbott's Compounding Pharmacy, Inc.
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 43 recalled by Abbott's Compounding Pharmacy, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 43 products in this recall →Related recalls
Same manufacturer · Abbott's Compounding Pharmacy, Inc.
See all →- HighAbbott's Compounding Pharmacy Recalls Methylcobalamine Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Compounded Papaverine Phentolamine Products
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Compounded Products Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Compounded Products for Sterility Concerns
FDA (Drugs) · 2016-02-24
- SevereAbbott's Compounding Pharmacy Recalls Sterile Hydroxyprogesterone Due to Sterility Concerns
FDA (Drugs) · 2016-02-24
Same hazard · lack of sterility
See all →- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereWalgreens Lubricant Eye Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
Similar recalls
- HighCompounded Injectable Drug Recalled Due to Sterility Assurance Defect
FDA (Drugs) · 2022-11-09
- SevereThe Apothecary Recalls Sterile Medications Due to Sterility Assurance Issues
FDA (Drugs) · 2016-09-28
- HighPharmacy Compounded Injection Recalled for Sterility Assurance Failure
FDA (Drugs) · 2022-11-09
- SevereThe Apothecary Recalls Sterile Injection Medications Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-09-28
- SevereUS Compounding Recalls Bi-Mix Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereProstaglandin Compounded Sterile Products Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12